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Abstract
Background: Psychosis is a serious mental illness that typically emerges during early adulthood. The disorder is
characterized by inactivity, cognitive deficits and the need for ongoing support. Regular exercise has mood
enhancing and anxiolytic effects that could benefit this patient group. To date, few studies have examined the
effects of prescribed exercise on autonomy, health and cognitive functioning in psychosis.
Methods/Design: This is a single-center, randomized controlled trial (RCT) with a 3-month follow-up. Usual care
plus a 12-week supervised exercise program will be compared to usual outpatient care alone. The primary outcome
will be patient autonomy measured by the Camberwell Assessment of Need (CAN) schedule – clinician rated.
Secondary outcomes include cardiovascular risk factors, cognitive functioning, substance abuse, body awareness,
depression and mood state. Changes in inflammatory markers and microbiotica will be explored. The feasibility of
using patients as exercise trainers will also be assessed.
Discussion: The treatment potential for exercise in psychosis is large because most individuals with the disorder
are young and inactive. The study is one of the first to comprehensively assess the effects of regular exercise in
young adults with psychosis. Sessions will be closely supervised and adjusted to meet patient needs. Both the
feasibility and treatment effects of exercise interventions in psychosis will be discussed.
Trial registration: German Clinical Trials Register DRKS00008991 7 August 2015.
Keywords: Psychosis, Treatment, Exercise, Intervention
Background
Psychosis is a serious mental disorder characterized by a
loss of contact with reality and deterioration in social
and occupational functioning. The most serious form
of the disorder, schizophrenia, has a lifetime preva-
lence of 5.5 (SD = 4.5) in 1,000 persons [1]. The mean
age of onset is 18 years in males and 25 in females [2].
Schizophrenia is associated with elevated suicide rates and
an increased risk of premature death related to a range of
comorbid somatic conditions [3]. Rates of depression vary
between 25–81 % [4], and substance abuse is highly preva-
lent. Cognitive impairment is a core feature of schizophre-
nia, which can adversely affect occupational functioning
and life quality [5]. Deficits typically appear in attention,
declarative memory and higher-order problem solving [6].
The speed of processing, working and long-term memory
can also be affected, as are abilities that are essential to
school and working life. Several studies have proposed
that neuroinflammation and autoimmunity are involved
in the etiology and pathogenesis of schizophrenia [7, 8].
The stress-vulnerability model suggests that lowering bio-
logical vulnerability and reducing stress may help prevent
relapse. Reducing biological vulnerability with medication
remains a cornerstone of treatment. Increasingly, psycho-
social interventions have also focusing on resilience to
stress [9].
Inactivity is another key feature of psychosis; most
individuals with the disorder do not meet the minimum
physical activity levels recommended for general health
[10]. This is problematic because regular exercise has
positive neurobiological effects, which are likely to bene-
fit this patient group. For example, exercise affects the
hypothalamic-pituitary-adrenal (HPA) axis, which in
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turn modulates stress-reactivity [11, 12]. Exercise also
influences hippocampal cell proliferation [13], and sero-
tonergic release [14], producing an anti-depressant effect
when performed regularly. Regular physical activity has
been shown to lower systemic inflammation [15], which
may be of importance in psychotic patients. According
to three Cochrane reviews, physical exercise has moder-
ate effects on depression equivalent to anti-depressant
treatment [16–18]. Other beneficial effects include im-
proved sleep quality [19] and increased neural growth
factor expression, which affects neurogenesis, learning
and memory [20]. Recent studies suggest that exercise
may also reduce cravings for alcohol and other drugs in
substance dependent individuals [21, 22]. Despite this
evidence, few studies have explored the effects of
exercise in patients with psychosis, a physically inactive
patient group with high rates of comorbid depression
and substance abuse.
The primary objective of FitForLife is to examine the
effects of a 12-week physical exercise program on auton-
omy in young adults with psychosis. Secondary aims are
to explore changes in general health, cognitive ability,
substance use, body awareness, depression and mood
states. Blood and feces samples will be requested to as-
sess changes in inflammatory markers and microbiotica.
The feasibility of educating patients as exercise trainers
will also be assessed. We hypothesize that the interven-
tion will lead to improvements in all outcomes assessed.
Specific research questions
Specific research questions are as follows:
1. Can a supervised exercise intervention for psychosis
improve patient autonomy (that is, their need for
care and assistance)?
2. What are the effects of regular exercise on
cardiovascular risk factors (body weight, waist and
hip circumference, blood pressure, blood lipids),
maximal oxygen uptake (VO2 max), and
inflammatory markers?
3. Can regular exercise improve cognitive functioning
and body awareness in psychosis?
4. Is regular exercise associated with reduced
comorbidity, specifically, depression, anxiety and
substance abuse?
5. What are the effects of regular exercise on symptom
recurrence and hospitalization?
6. Does regular exercise improve the microbiotic
profile of patients, and are these changes correlated
with other health-related outcomes?
7. What are the short-term (acute) effects of exercise
on self-rated mood in psychosis?
8. Is it feasible to train psychotic patients as exercise
trainers and role models?
Method/Design
Setting
All patients will be recruited via the ‘Midhagen’ out-
patient unit for young adults (aged 18 to 45 years) with
first-episode psychosis. Located in central Stockholm,
the clinic delivers need-based care with the aim of
maximizing patient autonomy and life quality. Various
interventions are offered, including counselling-support,
medication and education. Clinical staff are specialized
in psychiatry, clinical psychology or psychiatric nursing.
Approximately 200 patients are registered at the clinic
each year, and the majority has schizophrenia. A
minority have schizoaffective disorder or drug-induced
psychosis. If the number of patients willing to participate
is insufficient, the study will extend to a second psychi-
atric outpatient clinic located about 20 kilometers out-
side Stockholm.
Study design, randomization and blinding
Single-center, two-group parallel, randomized controlled
trial (RCT) with a 3-month post-treatment assessment
(study end-point). Random allocation of the patients
will be performed externally. A psychiatric nurse and
research-assistant will be trained to conduct patient
assessments before and after treatment. Assessors will, in
most instances, be aware of the patient’s treatment alloca-
tion. Genuine blinding of assessors is not feasible given
the high degree of research assistant involvement in the
project as a whole. It is also likely that many patients will
discuss their treatment will the assessors. Patients ran-
domized to the exercise intervention will also receive
usual care for psychosis administered by their clinician.
The comparison group in this study will be an active
(wait-list) control group that will receive need-based care
at the clinic only. This will normally consist of medication
and counseling/supportive therapy as required. Changes
on key outcomes will be compared before and after treat-
ment within and between the two allocated groups. All
patients in the control condition will subsequently be
offered the exercise intervention after the first group have
completed treatment; that is, 12 weeks after the baseline
assessment. This second round of exercise sessions will be
led by patients with psychosis who have been educated as
trainers (see description below). The feasibility of using
patients as trainers will be assessed through a qualitative
survey conducted at the end of the study and reported
separately. The flow of participants through the trial is
shown in Fig. 1.
Affective responses to exercise
To assess the affective response of patients to acute
(short-term) bouts of exercise, a separate study will be
embedded within the RCT design. Patients will complete
the Positive and Negative Affect Scale (PANAS) [23] 5
Forsell et al. Trials  (2015) 16:553 Page 2 of 6
to 10 minutes before and after each exercise session.
Changes in mood states over time will be examined and
reported. Affective responses to acute bouts of exercise
have been shown to predict rates of exercise adherence,
and are therefore relevant to measure. Specifically, posi-
tive mood responses during and following exercise are
associated with higher rates of future exercise adherence,
whereas negative affective responses have been linked to
lower rates of adherence [24].
Ethics
The study has received ethical approval by the Regional
Ethics Committee (Regionala Etikprovninsnämnden, EPN),
Stockholm, number 2015/808-31/2. The trial is registered
with German Clinical Trials Register: DRKS00008991.
Informed consent will be obtained from all participants
prior to inclusion. All patients must agree to participate
voluntarily and will be free to withdraw from the study at
any time. Patients randomized to usual care who express
interest in receiving the exercise intervention will be given
the opportunity to participate in the exercise treatment
after the first wave of treatment is completed.
Participants
The study will include 80 patients: 40 will receive the ex-
ercise intervention, and 40 will serve as active (wait-list)
controls. Both new and existing patients will be invited
to participate.
Inclusion criteria: All patients attending the clinic with a
diagnosed first-episode psychotic disorder who provide in-
formed consent and wish to participate will be included.
Exclusion criteria: Patients with severe somatic
disorders or injuries that make it difficult or unsafe to
exercise will be excluded. Patients with a history of
cardiovascular disease and pregnant women will also
be excluded.
Initial screening:
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Usual care plus
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wave of treatment is 
completed. Data from these 
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Fig. 1 CONSORT diagram showing the proposed flow of participants through FitForLife. FitForLife is a randomized controlled trial (RCT) comparing
the effects of standard outpatient treatment for psychosis to standard care plus a 12-week supported exercise intervention. The trial includes an
embedded study of the acute effects of exercise on mood states
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Screening interview
A research assistant or nurse will initially perform a brief
screening interview at the clinic to determine patient
eligibility using the criteria outlines above. Suitable
patients will then be invited to participate in the trial,
informed consent obtained, and a baseline assessment
conducted prior to randomization.
Baseline and post-treatment assessments
Assessments will include the following domains/measures:
1. Demographics will be assessed, including age,
gender, occupation, sick leave (baseline only; taken
from patient files).
2. Diagnosis, age of symptom onset, number of
psychosis-related hospital admissions, medication
use (also from patient files, where available) will be
assessed.
3. Autonomy will be assessed by the Camberwell
Assessment of Need (CAN) – clinician rated
questionnaire [25]. CAN is a validated instrument
used to understand the health and social needs of
adults with severe mental health problems. It
covers 22 domains of an individual’s life, such as
accommodation, self-care, daytime activities,
psychological distress, physical health and
relationships.
4. Depression severity will be measured using the
Montgomery-Åsberg Depression Rating Scale
(MADRS) [26].
5. Habitual physical activity levels ‘in a typical week’
(frequency and intensity) will be assessed using a
questionnaire developed by the Swedish Institute of
Sport and Health Science (GIH:Gymnastik- och
idrottshögskolan) and previously used in a
nationwide lifestyle study [27].
6. Fitness will be assessed using a modified Åstrand
VO2-submax cycle ergometer test [28].
7. Height and weight will be assessed to estimate body
mass index (BMI), waist and hip circumference and
blood pressure.
8. Body Awareness will be assessed by the Body
Awareness Scale [29].
9. Cognitive ability will be assessed by the CogState Brief
Battery [30], Trailmaking [31] and Stroop tests [32].
10. Blood and stool samples will be taken to test fatty
acids, inflammatory markers (for example, IL-10,
IL-1ra and TNF-alpha) and microbiotic profile
(samples to be assessed within the Institute for
Molecular Medicine and Surgery, Karolinska Institutet).
Exercise intervention
Exercise sessions will be designed and supervised by ex-
ercise science graduates from the Swedish School of
Health and Sports Medicine (GIH), under the super-
vision of an experienced exercise physiologist. GIH has
extensive experience developing training protocols for
patients with various health conditions. The graduates
will also educate and support the six patients who volun-
teer to work as exercise trainers during the second phase
of the study. Exercise sessions will be available five
times/week during the 12-week intervention, and partici-
pants will be encouraged to attend three sessions each
week. The training sessions will consist of a 5 to 10 minute
warm-up, 30 minutes of aerobic training, 15 minutes of
body-weight resistance training, and a 5 to 10 minute
cool-down (about 1 hour in total). Participants will be
encouraged to train at a level appropriate to their current
fitness and ability, with the aim of reaching a moderate
intensity (that is, three times or more higher that resting
metabolic rate). Intensity and total training volume will be
estimated from the accelerometer data and used in the
analyses. To maximize participation and adherence, we
aim to offer exercise classes that appeal to the partici-
pants, with varying types of exercises and shifting between
indoor and outdoor activities. However, most sessions will
be conducted indoors; outdoor sessions are dependent on
weather conditions. Regular meetings will be scheduled
with the trainers and participants to discuss the classes,
and there will be capacity to adjust the activities. Six pa-
tient (three males, three females) will be invited to become
exercise trainers for the second round of patients. Exercise
science students from GIH will train these patients. The
selection of patient-trainers will be made with clinical
staff; six patients will be paid to lead regular exercise clas-
ses. The intention is that the trainers will serve as role
models to increase participant empowerment.
Objective assessment of physical activity
All patients randomized to the exercise group will be
provided a hip-worn accelerometer (‘FitBit Zip’ device)
to objectively measure and record daily physical activity
levels, including the total number of steps taken and
minutes/hours spent in light, moderate and vigorous
activity. The device enables patients to set activity goals
and receive daily feedback. It can be used with Smart-
phones and computers, and it is possible to store data
from multiple devices centrally. This will be achieved
using the online ‘Fitabase’ program.
Statistical analysis
Participant characteristics, stratified by treatment group
(exercise versus active control) will be presented. Base-
line differences will be tested using t-tests for continuous
variables and Chi-square tests for categorical outcomes.
Parametric test assumptions will be examined and re-
ported. Nonparametric data will be transformed or alter-
natively analyzed using nonparametric statistical tests.
Forsell et al. Trials  (2015) 16:553 Page 4 of 6
Multiple imputation will be used to replace missing in-
ternal values where appropriate. Within-group changes
in the primary outcome (autonomy) and secondary out-
comes (health, cognitive ability, substance use, etcetera)
will be analyzed using paired sample t-tests. To address
the primary research question, intention-to-treat ana-
lyses will be performed. The effect of group allocation
on autonomy and all secondary outcomes at 3 month
follow-up will be assessed using linear regression
models (logistic for binary outcomes), using both the
mean difference (baseline to 3 months) and total scores
as dependent variables. Where the total score is used as
the outcome, baseline group differences in covariates
will be adjusted. Data from individual accelerometers
will be pooled to objectively assess changes in physical
activity levels before and after treatment. All analyses
will be performed using SPSS 22.0. All tests will be
two-sided and P-values of less than 0.05 will be consid-
ered statistically significant.
Discussion
A Cochrane review from 2010 concluded that exercise
interventions for schizophrenia are feasible and may
have beneficial psychobiological effects [33]. However,
only three studies fulfilled the review inclusion criteria
with small sample sizes of 12, 13 and 61 patients,
respectively. A recent systematic review and meta-
analysis including eight studies showed only a modest
increase in levels of exercise and no changes in symp-
toms or body mass index following exercise [34]. How-
ever, the studies varied widely in exercise treatments,
sample size, age-range and outcomes measured. Only
two studies used a validated measure of exercise as the
primary outcome, the 6-minute walking test. Moreover,
exercise intensity was not measured; thus, benefits of
the interventions were difficult to compare [34]. The ef-
fects of exercise on cognition in psychosis have rarely
been studied. One study reported a 34 percent im-
provement in short-term memory, but included only
eight patients and eight controls [35].
The treatment potential for exercise in psychosis is
large because most individuals with the disorder are
sedentary and inactive. This study will be one of the
first to comprehensively assess the health-related ef-
fects of regular exercise in young adults with psychosis.
Exercise interventions for this patient group need to be
carefully adjusted and supervised; motor coordination
and sensory integration may be impaired, which can
adversely affect coordination and body awareness [36].
Supervision of exercise programs has been shown to in-
crease adherence and improve outcomes in depression
studies [37]. For these reasons, the current study will
involve closely supervised, tailored exercise sessions
that will be adjusted to meet patient needs. The
objective assessment of physical activity is another im-
portant design consideration, as memory and recall
may be impaired. Some novice exercisers could be un-
familiar with the sensation of aerobic activity, and may
interpret these feelings as distress or anxiety. Care will
be taken to ensure that novice exercisers begin with
low-intensity exercises so they have time to become
familiar with the physical and affective changes often
associated with exercise [38]. All classes will be super-
vised by qualified exercise-trainers, and a psychiatric
nurse will be readily available should patients feel dis-
tressed or require assistance. While psychosocial inter-
ventions in psychosis have expanded rapidly in recent
years, exercise interventions have received less atten-
tion. Results will be used to inform clinicians and re-
searchers about the feasibility and effects of exercise as
an adjunct treatment for psychosis.
Trial status
The trial is due to commence in September 2015.
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